INS and diabetes mellitus: Previous studies employing tracers in patients without diabetes have shown a number of metabolic abnormalities associated with liver fat, including increased FFA and glycerol turnover, impaired suppression of lipolysis by insulin, increased hepatic triglyceride export, de novo lipogenesis, and hepatic insulin resistance (5, 9, 11).